搜索临床试验以:CD19-specific chimeric antigen receptor
总计418个结果
-
Bioray LaboratoriesWuhan Union Hospital, China; Zhejiang University; Institute of Hematology & Blood Diseases Hospital...招聘中
-
Dipenkumar ModiGenmab招聘中
-
University Medical Center Groningen招聘中
-
National Cancer Institute (NCI)终止淋巴瘤,B细胞 | 慢性淋巴细胞白血病 | 淋巴瘤,非霍奇金 | B细胞慢性淋巴细胞白血病美国
-
University of FloridaNational Institute of General Medical Sciences (NIGMS); Surgical Infection Society完全的
-
Shenzhen Geno-Immune Medical InstituteThe Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children's Hospital; ShiJiaZhuang...招聘中
-
Lazaros LekakisGenentech, Inc.招聘中难治性非霍奇金淋巴瘤 | 复发性非霍奇金淋巴瘤 | 侵袭性非霍奇金淋巴瘤美国
-
H. Lee Moffitt Cancer Center and Research InstituteProgenics Pharmaceuticals, Inc.招聘中
-
Shenzhen Geno-Immune Medical InstituteShenzhen Second People's Hospital; Shenzhen Third People's Hospital招聘中
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health... 和其他合作者完全的
-
Mayo ClinicPaul E. Evans MD; William J. Sandborn MD; Edward V. Loftus MD; Thomas C. Smryk MD; Willaim Tremaine...完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Henan Cancer HospitalHenan Hualong Biotechnology Company未知
-
Nantes University HospitalUMR892完全的
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College... 和其他合作者完全的
-
Tianjin Medical University Cancer Institute and...未知
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止造血和淋巴细胞肿瘤 | 恶性实体肿瘤 | 复发性套细胞淋巴瘤 | 转移性肺非小细胞癌 | 难治性慢性淋巴细胞白血病 | IIIA 期肺癌非小细胞癌 AJCC v7 | 复发性急性淋巴细胞白血病 | 转移性三阴性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | 不可切除的肺非小细胞癌 | IIIB 期肺癌非小细胞癌 AJCC v7 | IV 期肺癌非小细胞癌 AJCC v7 | III 期肺癌非小细胞癌 AJCC v7美国
-
University College, LondonDeutsche Krebshilfe e.V., Bonn (Germany); European Union; The Leukemia and Lymphoma Society; JP... 和其他合作者终止
-
Ann-Sofie BackmanThe Swedish Research Council招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)主动,不招人复发性胶质母细胞瘤 | 复发性恶性胶质瘤 | 难治性恶性胶质瘤 | 复发性 WHO III 级神经胶质瘤 | 复发性 WHO II 级神经胶质瘤 | 难治性胶质母细胞瘤 | 难治性 WHO II 级神经胶质瘤 | 难治性 WHO III 级神经胶质瘤美国
-
National Cancer Institute (NCI)完全的淋巴瘤,大 B 细胞,弥漫性 | 淋巴瘤,T 细胞,外周 | 淋巴瘤、大细胞、间变性 | 淋巴瘤,结外 NK-T 细胞 | 肠病相关的T细胞淋巴瘤美国
-
University of California, San FranciscoKhon Kaen University; King Chulalongkorn Memorial Hospital; Huang Pacific Foundation招聘中
-
University Hospital, GhentUniversity Ghent; Kom Op Tegen Kanker主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人